MARAbio Systems, Inc.

About MARAbio Systems, Inc.

MARAbio is dedicated to detecting and mitigating Maternal Autoantibody Related Autism (MARA). Their vision is a world where the most severe effects of autism do not occur, achieved through early detection and intervention using precision technology.

Products & Services

MARA Detection Test:A simple blood test for mothers, conducted prior to pregnancy or as early as birth, to predict the likelihood of MARA in a child with over 90% accuracy, even before clinical symptoms appear.

Therapeutic Interventions:Research and development efforts focused on creating specific therapeutic interventions for MARA following detection.

Specialties

Maternal Autoantibody Related Autism (MARA) Detection Precision Technology for Autism Prediction Early Intervention Strategies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 19000000 MR: - FA: $19 million FAN: 19000000	D: 2024-10-08 FD: 2024-10-08	1 investors

Series A Latest

2024-10-08

$19.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Judy Van de Water, PhD

Founder, Chief Science Advisor

M

Michael S. Paul, PhD

Chief Executive Officer

E

E. Robert Wassman, MD

Chief Medical Officer, Head of Clinical Development

E

E. Robert (Bob) Wassman, MD

Chief Medical Advisor, Head of Clinical Development

J

James N. Woody, MD, PhD

Chief Science Officer

M

Mags McInerney, PhD MBA

Head of Assay Development

View 25 more team members with Pro

Unlock Full Team Directory

Recent News